IL13 and clostridium difficile infection: Treatment with IL‐33 dampens the inflammatory response linked to CDI by reducing pro‐inflammatory cytokines such as IL‐1β, IL‐6, and IL‐23, while boosting anti‐inflammatory cytokine production like IL‐4, IL‐5, and IL‐13.